Advances in Myelofibrosis: A Clinical Case Approach

  Advances in Myelofibrosis: A Clinical Case Approach
 
 
Advances in Myelofibrosis: A Clinical Case Approach
Release Date: February 16, 2013
Expiration Date: February 16, 2014
(CME credit is no longer available for this activity)
Agenda
Myelofibrosis: Diagnostic and Therapeutic Dilemma (duration 04:11)
Ronald Hoffman, MD, Chair
Mount Sinai School of Medicine, New York, USA
Case 1: ET/Early phase PMF: Are they different and does it matter? (duration 06:09)
Attilio Orazi, MD (presented by Ronald Hoffman)
Weill Cornell Medical College, New York, USA
Diagnosis of PMF and its relationship to essential thrombocythemia (duration 15:30)
Attilio Orazi, MD (presented by Ronald Hoffman)
Weill Cornell Medical College, New York, USA
Case 2: Symptomatic myelofibrosis (duration 05:30)
Claire Harrison, MD
Guy's and St. Thomas' Hospitals, London, UK
Update of JAK inhibitors for PMF (duration 22:35)
Claire Harrison, MD
Guy's and St. Thomas' Hospitals, London, UK
Role of HDAC inhibitors in PMF (duration 17:05)
John Mascarenhas, MD
Mount Sinai School of Medicine, New York, USA
Case 3: Evolution of myelofibrosis to acute leukemia (duration 06:38)
John Mascarenhas, MD
Mount Sinai School of Medicine, New York, USA
Development of novel drug combinations (duration 20:13)
Kapil Bhalla, MD
The University of Kansas Medical Center, Kansas City, USA
The transplant option for PMF (duration 12:10)
Richard Champlin, MD
The University of Texas MD Anderson Cancer Center, Houston, USA
 
  Supported by an educational grant from:

Incyte

  Sponsored by:

Hemedicus

 
  This program is only available to registered users

If you have already registered, please click here to login and continue.
Otherwise, please click here to register first.